ES2105971B1 - ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION. - Google Patents

ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Info

Publication number
ES2105971B1
ES2105971B1 ES9501567A ES9501567A ES2105971B1 ES 2105971 B1 ES2105971 B1 ES 2105971B1 ES 9501567 A ES9501567 A ES 9501567A ES 9501567 A ES9501567 A ES 9501567A ES 2105971 B1 ES2105971 B1 ES 2105971B1
Authority
ES
Spain
Prior art keywords
hydroxybenzoate
antibiotic
inflammatory composition
polyethylene glycol
otic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9501567A
Other languages
Spanish (es)
Other versions
ES2105971A1 (en
Inventor
Carreras Manuel Roig
Vidal Carlos Montserrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Priority to ES9501567A priority Critical patent/ES2105971B1/en
Publication of ES2105971A1 publication Critical patent/ES2105971A1/en
Application granted granted Critical
Publication of ES2105971B1 publication Critical patent/ES2105971B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

COMPOSICION ANTIBIOTICA/ANTIINFLAMATORIA DE APLICACION OTICA COMPRENDE: 0.1-0.4 G DE CIPROFLOXACINO, 0.2-1.5 G DE HIDROCORTISONA, 0.3-0.8 G DE ACIDO LACTICO AL 20%; 0.3-0.6 G DE ACIDO CLORHIDRICO 1M, 1-3 G DE GLUCOSA, 1-3 G DE UN VISCOSIZANTE (PREFERIBLEMENTE POLIVINILPIRROLIDONA), 30-60 G DE UN CODISOLVENTE (PREFERIBLEMENTE PROPILENGLICOL O POLIETILENGLICOL), 1-3 G DE POLISORBATO POLIOXIETILENADO, Y 0.01-0.08 G DE UN AGENTE CONSERVANTE ELEGIDO ENTRE P-HIDROXIBENZOATO DE METILO, P-HIDROXIBENZOATO DE ETILO Y P-HIDROXIBENZOATO DE PROPILO. TIENE UTILIDAD PARA EL TRATAMIENTO TOPICO DE LA OTITIS, ESPECIALMENTE DE LA OTITIS MEDIA ACOMPAÑADA DE PROCESO INFLAMATORIO GENERAL. CONLLEVA LA VENTAJA DE QUE SE PUEDE APLICAR A NIÑOS, Y DE QUE NO PRESENTA EL RIESGO DE OTOTOXICIDAD EN CASOS DE PERFORACION DEL TIMPANO, ASOCIADO A OTRAS COMBINACIONES DE ANTIBIOTICOS Y ANTIINFLAMATORIOS QUE SE USAN POR VIA TOPICA.ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION INCLUDES: 0.1-0.4 G OF CIPROFLOXACINO, 0.2-1.5 G OF HYDROCORTISONE, 0.3-0.8 G OF LACTIC ACID AT 20%; 0.3-0.6 G OF HYDROCHLORIC ACID 1M, 1-3 G OF GLUCOSE, 1-3 G OF A VISCOSIZANT (PREFERABLY POLYVINYLPYROLIDONE), 30-60 G OF A CO-SOLVENT (PREFERABLY PROPYLENE GLYCOL, POLYETHYLENE GLYCOL), 1-3 G OF POLYETHYLENE GLYCOL, AND 0.01-0.08 G OF A PRESERVING AGENT CHOSEN BETWEEN METHYL P-HYDROXYBENZOATE, ETHYL P-HYDROXYBENZOATE AND PROPYL P-HYDROXYBENZOATE. IT IS USEFUL FOR THE TOPICAL TREATMENT OF OTITIS, ESPECIALLY OF OTITIS MEDIA ACCOMPANIED BY A GENERAL INFLAMMATORY PROCESS. IT HAS THE ADVANTAGE THAT IT CAN BE APPLIED TO CHILDREN, AND THAT IT DOES NOT PRESENT THE RISK OF OTOTOXICITY IN CASES OF PERFORATION OF TIMPANO, ASSOCIATED WITH OTHER COMBINATIONS OF ANTIBIOTICS AND ANTI-INFLAMMATORIES USED BY VIA TOPICA.

ES9501567A 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION. Expired - Lifetime ES2105971B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9501567A ES2105971B1 (en) 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9501567A ES2105971B1 (en) 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Publications (2)

Publication Number Publication Date
ES2105971A1 ES2105971A1 (en) 1997-10-16
ES2105971B1 true ES2105971B1 (en) 1998-07-01

Family

ID=8291261

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501567A Expired - Lifetime ES2105971B1 (en) 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Country Status (1)

Country Link
ES (1) ES2105971B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160090B1 (en) * 2000-03-16 2002-07-01 Vita Invest Sa Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration
ES2171147B1 (en) * 2001-02-06 2003-12-16 Esteve Labor Dr PREPARATION FOR VETERINARY USES.
ES2245611B1 (en) * 2004-06-29 2007-03-16 Laboratorio Reig Jofre, S.A. PHARMACEUTICAL COMPOSITION FOR OTOTOPIC USE.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704907A1 (en) * 1987-02-17 1988-08-25 Bayer Ag TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
ES2065846B1 (en) * 1993-04-20 1995-10-01 Cusi Lab PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.

Also Published As

Publication number Publication date
ES2105971A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
BR9714287A (en) Crystalline antibiotic called 6-o-metilerithromycin solvate form 0, 6-o-metilerithromycin solvate form 0, composition, processes for treating bacterial infections in a host mammal in need of such treatment and for the preparation of 6-o-metilerithomycin solvate the 0, 6-o-metilerithromycin form 0 - ethanolate, suspension for oral administration, and the 6-o-metilerithromycin solvate complex the 0-carbomer form.
BRPI9913945B8 (en) Rapidly acting pharmaceutical composition for the sublingual administration of a pharmaceutical agent for the treatment of acute disorders
ES2187201T3 (en) USE OF STEROLES AND STEROLESTERS TO NANOESCALA.
ES2161288T3 (en) COMPRESSED CLOSED WITH POLYMER THAT INCLUDES AMOXYCLINE AND CLAVULANATE.
FI900052A0 (en) COMPOSITION AND BEHANDLINGSMETODER FOR HEMORROJDER AND ANNAT.
MX9202407A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION.
ES2094906T3 (en) COMPOSITIONS FOR THE TOPIC ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS.
ATE208772T1 (en) PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
ES2154287T3 (en) PROCEDURE TO MODIFY THE GROWTH OF HAIRS AND / OR HAIRS AND COMPOSITIONS USED FOR THIS EFFECT.
ES2079994A1 (en) Pharmaceutical formulation comprised of polymyxin-trimethoprim and an anti-inflammatory drug for ophthalmic and optic topical use.
AR033342A1 (en) A TOPIC OR INTRANASAL OTHICAL COMPOSITION TO TREAT OTICO PAIN AND THE TOPICAL USE OF KAPA OPIOID AGONISTS TO TREAT OTICO PAIN
CA2254079A1 (en) Androstene derivatives
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
IT1235358B (en) 17BETA-OH 19-NOR STEROID DERIVATIVES REPLACED IN 17ALFA, PREPARATION PROCEDURE, THEIR USE AS MEDICATIONS AND PHARMACEUTICAL COMPOSITIONS THAT COMPOSE THEM
ES2105971B1 (en) ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
ES2088742B1 (en) ANTIBIOTIC COMPOSITION OF OTIC APPLICATION.
ATE133680T1 (en) OLIGOSACCHARIDE DERIVATIVES AND THEIR USE IN REMEDIES
NO964915L (en) Transdermal delivery of antiepileptic drugs
IE40957L (en) 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine
ES2123821T3 (en) SPRAY FORMULATION THAT HAS A REFRESHING EFFECT.
AR019724A2 (en) PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF MELLITUS DIABETES AND ASSOCIATED CONDITIONS
ES500185A0 (en) A METHOD FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF A GLYCOSIDIC OR SIMILAR ANTIBIOTIC.
GB1359226A (en) Propylene carbonate medicament base composition
BALLABIO et al. Topical hydrocortisone in pleuropericardial exudations

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971016

Kind code of ref document: A1

Effective date: 19971016